Top Markets
#1 Helium Helium +110.93%
#2 MowCat MowCat +96.55%
#3 Seeker Seeker +80.20%
#4 AI XOVIA AI XOVIA +47.49%
#5 UnifAI Network UnifAI Network +33.21%
#6 Pons Pons +31.52%
#7 Bounce Bounce +29.43%
#8 TENDIES TENDIES +26.01%
#9 Tensor Tensor +23.88%
#10 pipedog pipedog +21.51%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Rank in Stocks #11593
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Share Price
$29.06
Last synced: 2023-02-23
Market Cap
$682.73M
Change (1 day)
-0.48%
Change (1 year)
0.00%
Country
US
Trade CinCor Pharma, Inc. (CINC)

Category

Healthcare
Stock price history for CinCor Pharma, Inc. (CINC)
Highest end of day price: $29.26 on 2023-02-01

Lowest end of day price: $16.50 on 2022-01-01
Stock price history of CinCor Pharma, Inc. from 2022 to 2026
Annual Stock Price Performance
Year Performance
2023 146.11%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH